ArticlePloS one2026
From movement to METs: A validation of ActTrust® for energy expenditure estimation and physical activity classification in young adults.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Estimating physical activity (PA) levels is a challenging and expensive task. An alternative could be the use of actigraphy devices to estimate PA. This has been previously done to a number of devices, including ActiGraph® GT3X + . In this study, we validated ActTrust® against the widely used GT3X+ and compared activity counts to metabolic equivalents (METs) derived from indirect calorimetry during treadmill walking and running. Fifty-six young adults (34 men, 22 women) participated in controlled effort exercises including light, moderate, vigorous, and very vigorous activity intensities. We developed a linear model to estimate energy expenditure (EE) from movement count of combinations of devices placed at hip or wrist. We then estimated cut-off points for each intensity range. Our results showed correlations between treadmill speed and both METs (r = 0.95, p < 0.05) and movement counts from both GT3X+ and ActTrust devices placed either on the hip (r = 0.94, p < 0.05; r = 0.93, p < 0.05) or on the wrist (r = 0.88, p < 0.05; r = 0.88, p < 0.05), respectively. Our proposed model performed well with balanced accuracies above 0.77 for all intensity ranges and over 0.9 for light and moderate activity. This is the first study to model estimate and validate PA intensity thresholds on ActTrust® devices. Our findings support the use of ActTrust® devices as simple, cost-effective tool for 24-hour assessments of EE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.